No fatalities have been reported as of yet among those vaccinated with Sputnik V, Alexander Gintsburg, the director of the Gamaleya National Research Center for Epidemiology and Microbiology that developed Sputnik V, told an online briefing on Tuesday.
"Those who have been vaccinated, they are guaranteed that they won’t be...
The Russian Direct Investment Fund (RDIF) is holding negotiations with producers to increase Sputnik V coronavirus vaccine production volumes in the European Union, a RDIF spokesperson told reporters on Monday.
"RDIF has aimed for proactive interaction with all partners, including from Europe, from the very start of pandemic control, and...
Over the course of 2020, life expectancy for those living in Russia fell by more than two years, with the coronavirus death toll setting back ambitious government plans to consistently raise citizens’ average life spans, RT reported.
Last week, a draft government report on demographics was published by the May...
Russia’s Sputnik V anti-coronavirus vaccine has demonstrated the same level of effectiveness in all age groups, said Alexander Gintsburg, the director of the Gamaleya National Research Center for Epidemiology and Microbiology that developed Sputnik V, TASS reported.
"Sputnik V has demonstrated the same level of effectiveness in all age groups....
Russia’s coronavirus case tally rose by 10,083 in the past day, reaching 4,390,608, the anti-coronavirus crisis center told reporters on Sunday. In relative terms, the growth rate reached 0.23%, TASS writes.
The lowest growth rates were registered in the past day in the Tuva Republic (0.03%) and the Sakhalin Region...
As of March 9, over 268 million people have been vaccinated against COVID-19 globally, and currently, no deaths from the vaccines have been confirmed, the World Health Organization (WHO) told TASS, commenting on Denmark, Iceland, Italy and Norway suspending the use of the AstraZeneca vaccine after reports of thrombosis...
Doses of Russia’s Sputnik V vaccine against COVID-19 produced in Italy by Swiss-based pharmaceutical company Adienne Pharma & Biotech will not be available on the market until at least late 2021, Reuters reports.
Moscow’s RDIF sovereign wealth fund signed an agreement with Adienne earlier this week that will need approval...
Russia’s COVID-19 cases rose by 9,270 in the past day, reaching 4,360,823, the anti-coronavirus crisis center told reporters on Thursday.
In relative terms, the growth rate reached 0.21%, according to TASS.
The lowest growth rates were registered in the past day in the Tuva Republic (0.04%), the Sakhalin Region (0.05%), the...
The Russian Federal Medical Biological Agency (FMBA) is hoping to complete the registration process its coronavirus medicine dubbed Mir-19 in 2021, Director of the FMBA’s Immunology Institute Rakim Khaitov said in an interview with RT, TASS writes.
"Efficacy will be demonstrated in the second phase. It is hard to say...
